Division of Rheumatology

NYU Langone Health’s Division of Rheumatology, part of the Department of Medicine, is one of the leading rheumatology divisions in the country. Under the leadership of Jill P. Buyon, MD, division director, we pursue a tradition of excellence reflected in our tripartite mission of providing outstanding training of clinician–scientists; conducting innovative basic, translational, and clinical research; and offering the latest advances in clinical services.
News From NYU Langone Rheumatology
NYU Langone Health’s Psoriatic Arthritis Center Marks a Decade of Sustained Growth
Higher Psoriatic Arthritis Disease Burden Found Among Hispanic, Non-White Patients.
Jimin Tan, PhD receives 2-Year Arthritis National Research Foundation Grant
We are proud to announce that our AI Colton Scholar Jimin Tan, PhD was awarded a two-year grant from the Arthritis National Research Foundation (ANRF) titled, “Identification of gene dysregulation and therapeutic targets for psoriatic arthritis using novel machine learning approaches”. Drs. Jose U. Scher (NYU Colton Center Director) and Aris Tsirigos (Division of Precision Medicine co-Director) will serve as Mentors/Collaborators.
Dr. Tan's research uses advanced machine learning algorithms that learn patterns in patient data to better understand why PsA develops. The investigative team will study tissue samples from both the skin and joints of patients to find out what makes cells behave differently in PsA compared to skin psoriasis and other forms of arthritis. The ultimate goal of this research program is to help doctors better treat both the skin and joint symptoms of PsA, improving the lives of patients living with this challenging condition.
Rheumatology Education

Rheumatology Research

Rheumatology Faculty

Related News

Lupus Study Shows Who Should Monitor Fetal Heart Rate

Lupus Flare-Ups Linked to Specific Gut Bacterial Growth

Faculty Travel to Ukraine on Medical Missions

People with Lupus Benefit from COVID-19 Vaccine Booster

NYU Langone Leads Partnership to Study Autoimmune Diseases

NYU Langone Rheumatologists Present Latest Findings at ACR

Patients with Lupus Respond Less Well to COVID-19 Vaccine

Autoimmune Disorders Are on the Rise Among Older Adults

Enzyme Impairment May Enable Pathogenesis of Lupus Nephritis

Methotrexate Reduces Response to COVID-19 Vaccine

Most Lupus Patients Produce & Maintain COVID-19 Antibodies
